• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症相关成纤维细胞在肝细胞癌中的作用及中医药治疗价值

The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment.

作者信息

Jia Wentao, Liang Shufang, Cheng Binbin, Ling Changquan

机构信息

School of Traditional Chinese Medicine, Naval Medical University, Shanghai, China.

Department of Traditional Chinese Medicine, Changhai Hospital, Navy Medical University, Shanghai, China.

出版信息

Front Oncol. 2021 Nov 18;11:763519. doi: 10.3389/fonc.2021.763519. eCollection 2021.

DOI:10.3389/fonc.2021.763519
PMID:34868982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8636329/
Abstract

Invasion and metastasis are the main reasons for the high mortality of liver cancer, which involve the interaction of tumor stromal cells and malignant cells. Cancer-associated fibroblasts (CAFs) are one of the major constituents of tumor stromal cells affecting tumor growth, invasion, and metastasis. The heterogeneous properties and sources of CAFs make both tumor-supporting and tumor-suppression effects possible. The mechanisms for CAFs in supporting hepatocellular carcinoma (HCC) progression can be categorized into upregulated aggressiveness and stemness, transformed metabolism toward glycolysis and glutamine reductive carboxylation, polarized tumor immunity toward immune escape of HCC cells, and increased angiogenesis. The tumor-suppressive effect of fibroblasts highlights the functional heterogenicity of CAF populations and provides new insights into tumor-stromal interplay mechanisms. In this review, we introduced several key inflammatory signaling pathways in the transformation of CAFs from normal stromal cells and the heterogeneous biofunctions of activated CAFs. In view of the pleiotropic regulation properties of traditional Chinese medicine (TCM) and heterogeneous effects of CAFs, we also introduced the application and values of TCM in the treatment of HCC through targeting CAFs.

摘要

侵袭和转移是肝癌死亡率高的主要原因,这涉及肿瘤基质细胞与恶性细胞的相互作用。癌症相关成纤维细胞(CAFs)是影响肿瘤生长、侵袭和转移的肿瘤基质细胞的主要成分之一。CAFs的异质性特性和来源使得其既可能产生肿瘤支持作用,也可能产生肿瘤抑制作用。CAFs支持肝细胞癌(HCC)进展的机制可分为上调侵袭性和干性、向糖酵解和谷氨酰胺还原羧化转变代谢、使肿瘤免疫向HCC细胞免疫逃逸极化以及增加血管生成。成纤维细胞的肿瘤抑制作用突出了CAF群体的功能异质性,并为肿瘤-基质相互作用机制提供了新的见解。在本综述中,我们介绍了正常基质细胞转化为CAFs过程中的几个关键炎症信号通路以及活化CAFs的异质生物功能。鉴于中药的多效调节特性和CAFs的异质作用,我们还介绍了中药通过靶向CAFs治疗HCC的应用和价值。

相似文献

1
The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment.癌症相关成纤维细胞在肝细胞癌中的作用及中医药治疗价值
Front Oncol. 2021 Nov 18;11:763519. doi: 10.3389/fonc.2021.763519. eCollection 2021.
2
Cancer-associated fibroblasts promote the stemness of CD24 liver cells via paracrine signaling.肿瘤相关成纤维细胞通过旁分泌信号促进 CD24 肝干细胞的干性。
J Mol Med (Berl). 2019 Feb;97(2):243-255. doi: 10.1007/s00109-018-1731-9. Epub 2018 Dec 18.
3
Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.异质性癌症相关成纤维细胞的调控:激活信号通路的分子病理学。
J Exp Clin Cancer Res. 2020 Jun 16;39(1):112. doi: 10.1186/s13046-020-01611-0.
4
Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma.将癌症相关成纤维细胞鉴定为肝细胞癌的新靶点。
Cell Biosci. 2020 Oct 31;10(1):127. doi: 10.1186/s13578-020-00488-y.
5
Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma.癌相关成纤维细胞通过 IL6-STAT3 通路诱导 PDL1+中性粒细胞,从而促进肝癌中的免疫抑制。
Cell Death Dis. 2018 Apr 1;9(4):422. doi: 10.1038/s41419-018-0458-4.
6
Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.骨形态发生蛋白 4 为肝癌患者的肝成纤维细胞提供了支持癌症的表型。
J Gastroenterol. 2019 Nov;54(11):1007-1018. doi: 10.1007/s00535-019-01579-5. Epub 2019 Apr 2.
7
Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.从非小细胞肺癌中鉴定肿瘤相关成纤维细胞的不同群体,揭示 ST8SIA2 在癌细胞侵袭中的作用。
Neoplasia. 2019 May;21(5):482-493. doi: 10.1016/j.neo.2019.03.009. Epub 2019 Apr 9.
8
Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers.靶向促结缔组织增生性癌症中癌相关成纤维细胞、间充质干细胞和癌症干细胞之间的相互作用
Front Oncol. 2019 Jul 31;9:688. doi: 10.3389/fonc.2019.00688. eCollection 2019.
9
Cancer-associated fibroblasts endow stem-like qualities to liver cancer cells by modulating autophagy.癌症相关成纤维细胞通过调节自噬赋予肝癌细胞干细胞样特性。
Cancer Manag Res. 2019 Jun 24;11:5737-5744. doi: 10.2147/CMAR.S197634. eCollection 2019.
10
Cancer-associated Fibroblasts induce epithelial-mesenchymal transition the Transglutaminase 2-dependent IL-6/IL6R/STAT3 axis in Hepatocellular Carcinoma.肿瘤相关成纤维细胞通过 Transglutaminase 2 诱导肝细胞癌中的上皮间质转化及 IL-6/IL6R/STAT3 信号通路。
Int J Biol Sci. 2020 Jul 19;16(14):2542-2558. doi: 10.7150/ijbs.45446. eCollection 2020.

引用本文的文献

1
Targeting glutamine metabolism as a potential target for cancer treatment.将谷氨酰胺代谢作为癌症治疗的潜在靶点。
J Exp Clin Cancer Res. 2025 Jul 1;44(1):180. doi: 10.1186/s13046-025-03430-7.
2
Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications.肝细胞癌中的代谢重编程:免疫逃逸机制及治疗意义
Front Immunol. 2025 Apr 30;16:1592837. doi: 10.3389/fimmu.2025.1592837. eCollection 2025.
3
Evaluation of the Efficacy, Safety, and Clinical Outcomes of Ginsenosides as Adjuvant Therapy in Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review.

本文引用的文献

1
Huaier granule prevents the recurrence of early-stage hepatocellular carcinoma after thermal ablation: A cohort study.槐耳颗粒预防热消融术后早期肝癌复发的队列研究。
J Ethnopharmacol. 2021 Dec 5;281:114539. doi: 10.1016/j.jep.2021.114539. Epub 2021 Aug 21.
2
Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine Signaling.锌指 E-Box 结合同源盒 1 通过肿瘤去分化和肿瘤-基质旁分泌信号促进胆管癌进展。
Hepatology. 2021 Dec;74(6):3194-3212. doi: 10.1002/hep.32069. Epub 2021 Sep 28.
3
Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
人参皂苷作为辅助治疗肝细胞癌的疗效、安全性和临床结局的评价:荟萃分析和系统评价。
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241293790. doi: 10.1177/15347354241293790.
4
Targeting cancer-associated fibroblasts/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest.靶向癌相关成纤维细胞/肿瘤细胞串扰通过细胞周期阻滞抑制肝内胆管癌进展。
J Exp Clin Cancer Res. 2024 Oct 17;43(1):286. doi: 10.1186/s13046-024-03210-9.
5
Huaier granule improves liver inflammation and fibrosis and prevents recurrence in hepatitis B virus related hepatocellular carcinoma.槐耳颗粒可改善乙型肝炎病毒相关性肝细胞癌的肝脏炎症和纤维化,并预防复发。
Transl Cancer Res. 2024 Feb 29;13(2):569-578. doi: 10.21037/tcr-23-1347. Epub 2024 Feb 20.
6
[Hepatocellular Carcinoma-Derived Exosomes: Key Players in Intercellular Communication Within the Tumor Microenvironment].[肝癌衍生的外泌体:肿瘤微环境中细胞间通讯的关键参与者]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Jan 20;55(1):6-12. doi: 10.12182/20240160203.
7
Identification and validation of a cancer-associated fibroblasts-related scoring system to predict prognosis and immune landscape in hepatocellular carcinoma through integrated analysis of single-cell and bulk RNA-sequencing.通过单细胞和 bulk RNA-seq 整合分析鉴定和验证一个与癌症相关成纤维细胞相关的评分系统,以预测肝细胞癌的预后和免疫图谱。
Aging (Albany NY). 2023 Oct 18;15(20):11092-11113. doi: 10.18632/aging.205099.
8
Network Pharmacology Combined with Experimental Validation Reveals the Anti-tumor Effect of against Hepatocellular Carcinoma.网络药理学结合实验验证揭示了[具体药物名称]对肝癌的抗肿瘤作用。 (注:原文中“against Hepatocellular Carcinoma”前缺少具体药物名称)
J Cancer. 2023 Feb 13;14(4):505-518. doi: 10.7150/jca.76591. eCollection 2023.
9
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.外泌体 cargo 介导的肿瘤微环境代谢重编程。
J Exp Clin Cancer Res. 2023 Mar 10;42(1):59. doi: 10.1186/s13046-023-02634-z.
10
Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma.用于预测肝细胞癌预后和治疗结果的肿瘤突变负荷
Int J Mol Sci. 2023 Feb 8;24(4):3441. doi: 10.3390/ijms24043441.
癌相关成纤维细胞诱导的 M2 极化巨噬细胞通过纤溶酶原激活物抑制剂-1 途径促进肝细胞癌进展。
Int J Oncol. 2021 Aug;59(2). doi: 10.3892/ijo.2021.5239. Epub 2021 Jul 1.
4
The BAFF/NFκB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts.BAFF/NFκB 轴对于索拉非尼耐药 HCC 细胞与癌相关成纤维细胞之间的相互作用至关重要。
Cancer Sci. 2021 Sep;112(9):3545-3554. doi: 10.1111/cas.15041. Epub 2021 Jul 16.
5
Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts.肿瘤受到 I 型胶原的限制,可对抗癌症相关成纤维细胞的促肿瘤作用。
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI146987.
6
Sulfatase 2-Induced Cancer-Associated Fibroblasts Promote Hepatocellular Carcinoma Progression via Inhibition of Apoptosis and Induction of Epithelial-to-Mesenchymal Transition.硫酸酯酶2诱导的癌相关成纤维细胞通过抑制细胞凋亡和诱导上皮-间质转化促进肝细胞癌进展。
Front Cell Dev Biol. 2021 Apr 6;9:631931. doi: 10.3389/fcell.2021.631931. eCollection 2021.
7
Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein-coupled Receptor 68.金松双黄酮通过抑制 G 蛋白偶联受体 68 抑制激活的癌相关成纤维细胞抑制肝癌。
Mol Cancer Ther. 2021 Jun;20(6):1019-1028. doi: 10.1158/1535-7163.MCT-20-0150. Epub 2021 Mar 15.
8
Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression.癌症相关成纤维细胞介导的细胞间串扰促进肝细胞癌进展。
Hepatology. 2021 May;73(5):1717-1735. doi: 10.1002/hep.31792.
9
The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanism.LOXL2 在 HCC 转移前微环境形成中的病理意义及其相关分子机制。
Eur J Cancer. 2021 Apr;147:63-73. doi: 10.1016/j.ejca.2021.01.011. Epub 2021 Feb 19.
10
NOX1 inhibition attenuates the development of a pro-tumorigenic environment in experimental hepatocellular carcinoma.NOX1 抑制可减轻实验性肝细胞癌中促肿瘤环境的发展。
J Exp Clin Cancer Res. 2021 Jan 23;40(1):40. doi: 10.1186/s13046-021-01837-6.